Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murugabaskar Balan

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Oncogenesis|January 17, 2019
Activation of c-Met in cancer cells mediates growth-promoting signals against oxidative stress through Nrf2-HO-1Samik Chakraborty, Murugabaskar Balan, Evelyn Flynn, et al.
ASN Neuro|July 3, 2009
Brain injury expands the numbers of neural stem cells and progenitors in the SVZ by enhancing their responsiveness to EGFDhivyaa Alagappan, Deborah A Lazzarino, Ryan J Felling, et al.
ASN Neuro|June 15, 2013
Egr-1 is a critical regulator of EGF-receptor-mediated expansion of subventricular zone neural stem cells and progenitors during recovery from hypoxia-hypoglycemiaDhivyaa Alagappan, Murugabaskar Balan, Yuhui Jiang, et al.
Carcinogenesis|December 29, 2021
A Combination therapy using an mTOR inhibitor and Honokiol effectively induces autophagy through the modulation of AXL and Rubicon in renal cancer cells and restricts renal tumor growth following organ transplantationAkash Sabarwal, Johannes Wedel, Kaifeng Liu, et al.
The Journal of Biological Chemistry|February 4, 2015
Novel roles of c-Met in the survival of renal cancer cells through the regulation of HO-1 and PD-L1 expressionMurugabaskar Balan, Eduardo Mier y Teran, Ana Maria Waaga-Gasser, et al.
British Journal of Haematology|October 19, 2007
Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse modelBrian J Scaglione, Erica Salerno, Murugabaskar Balan, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2010
Antitumor activity of type I and type III interferons in BNL hepatoma modelWalid Abushahba, Murugabaskar Balan, Ismael Castaneda, et al.
Molecular Cancer Research : MCR|September 5, 2014
High-throughput drug screen identifies chelerythrine as a selective inducer of death in a TSC2-null settingDoug Medvetz, Yang Sun, Chenggang Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2007
Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virusJiaying Huang, Sergey V Smirnov, Anita Lewis-Antes, et al.
Plos Pathogens|April 30, 2016
Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus InfectionsJian-Da Lin, Ningguo Feng, Adrish Sen, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Oncogenesis|January 17, 2019
Activation of c-Met in cancer cells mediates growth-promoting signals against oxidative stress through Nrf2-HO-1Samik Chakraborty, Murugabaskar Balan, Evelyn Flynn, et al.
ASN Neuro|July 3, 2009
Brain injury expands the numbers of neural stem cells and progenitors in the SVZ by enhancing their responsiveness to EGFDhivyaa Alagappan, Deborah A Lazzarino, Ryan J Felling, et al.
ASN Neuro|June 15, 2013
Egr-1 is a critical regulator of EGF-receptor-mediated expansion of subventricular zone neural stem cells and progenitors during recovery from hypoxia-hypoglycemiaDhivyaa Alagappan, Murugabaskar Balan, Yuhui Jiang, et al.
Carcinogenesis|December 29, 2021
A Combination therapy using an mTOR inhibitor and Honokiol effectively induces autophagy through the modulation of AXL and Rubicon in renal cancer cells and restricts renal tumor growth following organ transplantationAkash Sabarwal, Johannes Wedel, Kaifeng Liu, et al.
The Journal of Biological Chemistry|February 4, 2015
Novel roles of c-Met in the survival of renal cancer cells through the regulation of HO-1 and PD-L1 expressionMurugabaskar Balan, Eduardo Mier y Teran, Ana Maria Waaga-Gasser, et al.
British Journal of Haematology|October 19, 2007
Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse modelBrian J Scaglione, Erica Salerno, Murugabaskar Balan, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2010
Antitumor activity of type I and type III interferons in BNL hepatoma modelWalid Abushahba, Murugabaskar Balan, Ismael Castaneda, et al.
Molecular Cancer Research : MCR|September 5, 2014
High-throughput drug screen identifies chelerythrine as a selective inducer of death in a TSC2-null settingDoug Medvetz, Yang Sun, Chenggang Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2007
Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virusJiaying Huang, Sergey V Smirnov, Anita Lewis-Antes, et al.
Plos Pathogens|April 30, 2016
Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus InfectionsJian-Da Lin, Ningguo Feng, Adrish Sen, et al.
Pageof 3